{"id":2345,"date":"2020-06-15T00:00:00","date_gmt":"2020-06-15T00:00:00","guid":{"rendered":"http:\/\/centogene.vl22350.dinaserver.com\/2345"},"modified":"2020-06-15T00:00:00","modified_gmt":"2020-06-15T00:00:00","slug":"centogene-przedstawia-wyniki-finansowe-i-postepy-firmy-za-pierwszy-kwartal-2020-r","status":"publish","type":"post","link":"https:\/\/www.centogene.com\/pl\/centogene-reports-first-quarter-2020-financial-results-and-corporate-progress\/","title":{"rendered":"CENTOGENE publikuje wyniki finansowe i post\u0119py firmy za pierwszy kwarta\u0142 2020 r."},"content":{"rendered":"<p>Cambridge, MA, USA i Rostock\/Berlin, Niemcy, 15 czerwca 2020 r. (Globe Newswire) \u2013 Centogene NV (Nasdaq: CNTG), sp\u00f3\u0142ka komercyjna skupiaj\u0105ca si\u0119 na rzadkich chorobach, kt\u00f3ra przetwarza rzeczywiste dane kliniczne i genetyczne w informacje przydatne pacjentom, lekarzom i firmom farmaceutycznym, przedstawi\u0142a dzi\u015b aktualizacj\u0119 post\u0119p\u00f3w swojej dzia\u0142alno\u015bci i opublikowa\u0142a wyniki finansowe za trzy miesi\u0105ce zako\u0144czone 31 marca 2020 r.<\/p>\n<ul>\n<li>Przychody w wysoko\u015bci 12,1 mln euro, co stanowi wzrost o 131 TP4T w por\u00f3wnaniu do trzech miesi\u0119cy zako\u0144czonych 31 marca 2019 r.<\/li>\n<li>Dalsza ekspansja globalnej, zastrze\u017conej platformy chor\u00f3b rzadkich, obejmuj\u0105cej oko\u0142o 3,0 miliard\u00f3w wa\u017conych punkt\u00f3w danych od ponad 530 000 pacjent\u00f3w reprezentuj\u0105cych 120 r\u00f3\u017cnych kraj\u00f3w (stan na 31 marca 2020 r.)<\/li>\n<li>Ponad 60 program\u00f3w biomarker\u00f3w, z czego ponad 25 program\u00f3w biomarker\u00f3w (obejmuj\u0105cych ponad 22 choroby) przesz\u0142o pierwsz\u0105 walidacj\u0119 przy u\u017cyciu spektrometrii masowej do 31 marca 2020 r.<\/li>\n<li>Rozszerzenie naszych test\u00f3w na COVID-19 oraz rozpocz\u0119cie produkcji i dystrybucji zestawu do pobierania pr\u00f3bek CentoSwab\u2122 w celu wsparcia globalnych dzia\u0142a\u0144 na rzecz walki z pandemi\u0105<\/li>\n<\/ul>\n<p>Prof. Arndt Rolfs, prezes CENTOGENE, powiedzia\u0142: \u201cW pierwszym kwartale 2020 roku nadal koncentrowali\u015bmy si\u0119 na naszej podstawowej dzia\u0142alno\u015bci, jak\u0105 jest precyzyjna diagnostyka medyczna i przyspieszenie rozwoju lek\u00f3w na rzadkie choroby dziedziczne, podejmuj\u0105c jednocze\u015bnie wa\u017cne kroki w celu efektywnego prowadzenia dzia\u0142alno\u015bci w czasie pandemii COVID-19 i wspierania szerszych dzia\u0142a\u0144 na rzecz walki z pandemi\u0105. Z przyjemno\u015bci\u0105 informujemy o wzro\u015bcie przychod\u00f3w o 131,4 tys. dolar\u00f3w w pierwszym kwartale 2020 roku, nap\u0119dzanym ci\u0105g\u0142ym doskonaleniem dzia\u0142alno\u015bci w naszych segmentach farmaceutycznym i diagnostycznym\u201d.\u201d<\/p>\n<p>Prof. Arndt Rolfs kontynuowa\u0142: \u201cW zwi\u0105zku z tym, \u017ce nadal dzia\u0142amy w \u015brodowisku COVID-19, z przyjemno\u015bci\u0105 informujemy, \u017ce chocia\u017c nasze szybkie, pocz\u0105tkowe dzia\u0142ania umo\u017cliwi\u0142y 751,4 tys. pracownik\u00f3w prac\u0119 zdaln\u0105, ostatnio uda\u0142o nam si\u0119 przywr\u00f3ci\u0107 prawie ca\u0142y nasz personel do biura poprzez wdro\u017cenie regularnych test\u00f3w. Ponadto, wykorzystali\u015bmy nasz\u0105 wiedz\u0119 diagnostyczn\u0105, aby opracowa\u0107 i zaoferowa\u0107 pacjentom na ca\u0142ym \u015bwiecie rozwi\u0105zanie do testowania SARS-CoV-2 \u2013 pocz\u0105wszy od systemu pobierania pr\u00f3bek \u2018CentoSwab\u2122\u2019, a sko\u0144czywszy na opracowanej przez CENTOGENE aplikacji do rejestracji pacjent\u00f3w i raportowania medycznego. Oczekujemy, \u017ce to rozwi\u0105zanie diagnostyczne pomo\u017ce spo\u0142eczno\u015bciom na ca\u0142ym \u015bwiecie powr\u00f3ci\u0107 do nowej normalno\u015bci i zapobiec kolejnym wybuchom epidemii. Wraz z ci\u0105g\u0142ym rozprzestrzenianiem si\u0119 pandemii COVID-19 na ca\u0142ym \u015bwiecie zacz\u0119li\u015bmy dostrzega\u0107 jej negatywny wp\u0142yw na nasz\u0105 dotychczasow\u0105 dzia\u0142alno\u015b\u0107, ale spodziewamy si\u0119, \u017ce nasze komercyjne testy na COVID-19 pomog\u0105 zr\u00f3wnowa\u017cy\u0107 ten negatywny wp\u0142yw\u201d.\u201d<\/p>\n<h2 class=\"h3\">Zwinna reakcja na COVID-19 i kontynuacja diagnostyki chor\u00f3b rzadkich<\/h2>\n<h5>Przewodzenie zr\u00f3wnowa\u017conym mo\u017cliwo\u015bciom testowania COVID-19<\/h5>\n<p>W marcu 2020 roku firma CENTOGENE og\u0142osi\u0142a rozpocz\u0119cie test\u00f3w na COVID-19. Zaczynaj\u0105c od pracownik\u00f3w i pracownik\u00f3w kluczowych w Rostocku w Niemczech, firma rozszerzy\u0142a ofert\u0119 test\u00f3w na domy opieki, a tak\u017ce uczni\u00f3w szk\u00f3\u0142 \u015brednich w ca\u0142ych Niemczech. Od maja 2020 roku firma oferuje swoje testy na ca\u0142ym \u015bwiecie. Ponadto, od kwietnia 2020 roku CENTOGENE zabezpieczy\u0142a niezb\u0119dne odczynniki i materia\u0142y, takie jak CentoSwab\u2122, aby wesprze\u0107 logistyk\u0119 i szybk\u0105 diagnostyk\u0119 COVID-19.<\/p>\n<h5>Przej\u0119cie laboratorium w Hamburgu w celu zwi\u0119kszenia mo\u017cliwo\u015bci testowych<\/h5>\n<p>W kwietniu 2020 roku firma CENTOGENE og\u0142osi\u0142a otwarcie nowego laboratorium w Hamburgu w Niemczech, aby zwi\u0119kszy\u0107 swoje mo\u017cliwo\u015bci testowania wirusa COVID-19. Laboratorium w Rostocku b\u0119dzie nadal koncentrowa\u0107 si\u0119 na podstawowej dzia\u0142alno\u015bci firmy, jak\u0105 jest rzadkie choroby dziedziczne, oraz na badaniach nad rozwojem biomarker\u00f3w.<\/p>\n<h5><strong>Kontakt dla medi\u00f3w<\/strong><\/h5>\n<p>CENTOGENE<br \/> Sun Kim<br \/> Dyrektor ds. strategii i relacji inwestorskich<br \/> <a href=\"mailto:investor.relations@centogene.com\" title=\"Napisz e-mail\">investor.relations(at)centogene(dot)com&nbsp;<\/a><\/p>\n<p> Bridie Lawlor<br \/> Doradztwo FTI<br \/> +1.917.929.5684<br \/> <a href=\"mailto:bridie.lawlor@fticonsulting.com\" title=\"Napisz e-mail\">bridie.lawlor(at)fticonsulting(dot)com<\/a><br \/> &nbsp;<\/p>","protected":false},"excerpt":{"rendered":"<p>W pierwszym kwartale 2020 roku nadal skupiali\u015bmy si\u0119 na naszej podstawowej dzia\u0142alno\u015bci, czyli zapewnianiu precyzyjnej diagnostyki medycznej i przyspieszaniu rozwoju lek\u00f3w na rzadkie choroby dziedziczne, podejmuj\u0105c jednocze\u015bnie wa\u017cne kroki maj\u0105ce na celu efektywne prowadzenie naszej dzia\u0142alno\u015bci w czasie pandemii COVID-19 i wspieranie szerszych dzia\u0142a\u0144 na rzecz zaradzenia tej pandemii.<\/p>","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"inline_featured_image":false,"footnotes":""},"categories":[1],"tags":[],"class_list":["post-2345","post","type-post","status-publish","format-standard","hentry","category-uncategorized"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>CENTOGENE Reports First-Quarter 2020 Financial Results and Corporate Progress | CENTOGENE<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.centogene.com\/pl\/centogene-przedstawia-wyniki-finansowe-i-postepy-firmy-za-pierwszy-kwartal-2020-r\/\" \/>\n<meta property=\"og:locale\" content=\"pl_PL\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"CENTOGENE Reports First-Quarter 2020 Financial Results and Corporate Progress | CENTOGENE\" \/>\n<meta property=\"og:description\" content=\"During the first quarter of 2020, we continued our focus on our core business of providing precise medical diagnosis of and accelerating drug development for rare hereditary diseases, while taking important steps to operate our business effectively during COVID-19 and support broader efforts to address this pandemic.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.centogene.com\/pl\/centogene-przedstawia-wyniki-finansowe-i-postepy-firmy-za-pierwszy-kwartal-2020-r\/\" \/>\n<meta property=\"og:site_name\" content=\"CENTOGENE\" \/>\n<meta property=\"article:published_time\" content=\"2020-06-15T00:00:00+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.centogene.com\/wp-content\/uploads\/2025\/03\/csm_centogene-diagnostics-priority-disease-03_5a57c07603.webp\" \/>\n\t<meta property=\"og:image:width\" content=\"740\" \/>\n\t<meta property=\"og:image:height\" content=\"416\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/webp\" \/>\n<meta name=\"author\" content=\"admincg\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Napisane przez\" \/>\n\t<meta name=\"twitter:data1\" content=\"admincg\" \/>\n\t<meta name=\"twitter:label2\" content=\"Szacowany czas czytania\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minuty\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.centogene.com\\\/centogene-reports-first-quarter-2020-financial-results-and-corporate-progress\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.centogene.com\\\/centogene-reports-first-quarter-2020-financial-results-and-corporate-progress\\\/\"},\"author\":{\"name\":\"admincg\",\"@id\":\"https:\\\/\\\/www.centogene.com\\\/#\\\/schema\\\/person\\\/d9b8738539a9ddb5de5a02a909d40b8b\"},\"headline\":\"CENTOGENE Reports First-Quarter 2020 Financial Results and Corporate Progress\",\"datePublished\":\"2020-06-15T00:00:00+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.centogene.com\\\/centogene-reports-first-quarter-2020-financial-results-and-corporate-progress\\\/\"},\"wordCount\":552,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/www.centogene.com\\\/#organization\"},\"articleSection\":[\"Uncategorized\"],\"inLanguage\":\"pl-PL\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/www.centogene.com\\\/centogene-reports-first-quarter-2020-financial-results-and-corporate-progress\\\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.centogene.com\\\/centogene-reports-first-quarter-2020-financial-results-and-corporate-progress\\\/\",\"url\":\"https:\\\/\\\/www.centogene.com\\\/centogene-reports-first-quarter-2020-financial-results-and-corporate-progress\\\/\",\"name\":\"CENTOGENE Reports First-Quarter 2020 Financial Results and Corporate Progress | CENTOGENE\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.centogene.com\\\/#website\"},\"datePublished\":\"2020-06-15T00:00:00+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.centogene.com\\\/centogene-reports-first-quarter-2020-financial-results-and-corporate-progress\\\/#breadcrumb\"},\"inLanguage\":\"pl-PL\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.centogene.com\\\/centogene-reports-first-quarter-2020-financial-results-and-corporate-progress\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.centogene.com\\\/centogene-reports-first-quarter-2020-financial-results-and-corporate-progress\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.centogene.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"CENTOGENE Reports First-Quarter 2020 Financial Results and Corporate Progress\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.centogene.com\\\/#website\",\"url\":\"https:\\\/\\\/www.centogene.com\\\/\",\"name\":\"CENTOGENE\",\"description\":\"Guiding Precision Medicine\",\"publisher\":{\"@id\":\"https:\\\/\\\/www.centogene.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.centogene.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"pl-PL\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/www.centogene.com\\\/#organization\",\"name\":\"CENTOGENE\",\"url\":\"https:\\\/\\\/www.centogene.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"pl-PL\",\"@id\":\"https:\\\/\\\/www.centogene.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/www.centogene.com\\\/wp-content\\\/uploads\\\/2026\\\/04\\\/CENTOGENE-Flower.png\",\"contentUrl\":\"https:\\\/\\\/www.centogene.com\\\/wp-content\\\/uploads\\\/2026\\\/04\\\/CENTOGENE-Flower.png\",\"width\":246,\"height\":246,\"caption\":\"CENTOGENE\"},\"image\":{\"@id\":\"https:\\\/\\\/www.centogene.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.linkedin.com\\\/company\\\/centogene\",\"https:\\\/\\\/www.youtube.com\\\/channel\\\/UClZxtN_laC1_ZtCdxkasdPQ\",\"https:\\\/\\\/www.instagram.com\\\/_centogene_\\\/\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.centogene.com\\\/#\\\/schema\\\/person\\\/d9b8738539a9ddb5de5a02a909d40b8b\",\"name\":\"admincg\",\"url\":\"https:\\\/\\\/www.centogene.com\\\/pl\\\/author\\\/admincg\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"CENTOGENE publikuje wyniki finansowe i post\u0119py firmy za pierwszy kwarta\u0142 2020 r. | CENTOGENE","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.centogene.com\/pl\/centogene-przedstawia-wyniki-finansowe-i-postepy-firmy-za-pierwszy-kwartal-2020-r\/","og_locale":"pl_PL","og_type":"article","og_title":"CENTOGENE Reports First-Quarter 2020 Financial Results and Corporate Progress | CENTOGENE","og_description":"During the first quarter of 2020, we continued our focus on our core business of providing precise medical diagnosis of and accelerating drug development for rare hereditary diseases, while taking important steps to operate our business effectively during COVID-19 and support broader efforts to address this pandemic.","og_url":"https:\/\/www.centogene.com\/pl\/centogene-przedstawia-wyniki-finansowe-i-postepy-firmy-za-pierwszy-kwartal-2020-r\/","og_site_name":"CENTOGENE","article_published_time":"2020-06-15T00:00:00+00:00","og_image":[{"width":740,"height":416,"url":"https:\/\/www.centogene.com\/wp-content\/uploads\/2025\/03\/csm_centogene-diagnostics-priority-disease-03_5a57c07603.webp","type":"image\/webp"}],"author":"admincg","twitter_card":"summary_large_image","twitter_misc":{"Napisane przez":"admincg","Szacowany czas czytania":"3 minuty"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.centogene.com\/centogene-reports-first-quarter-2020-financial-results-and-corporate-progress\/#article","isPartOf":{"@id":"https:\/\/www.centogene.com\/centogene-reports-first-quarter-2020-financial-results-and-corporate-progress\/"},"author":{"name":"admincg","@id":"https:\/\/www.centogene.com\/#\/schema\/person\/d9b8738539a9ddb5de5a02a909d40b8b"},"headline":"CENTOGENE Reports First-Quarter 2020 Financial Results and Corporate Progress","datePublished":"2020-06-15T00:00:00+00:00","mainEntityOfPage":{"@id":"https:\/\/www.centogene.com\/centogene-reports-first-quarter-2020-financial-results-and-corporate-progress\/"},"wordCount":552,"commentCount":0,"publisher":{"@id":"https:\/\/www.centogene.com\/#organization"},"articleSection":["Uncategorized"],"inLanguage":"pl-PL","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/www.centogene.com\/centogene-reports-first-quarter-2020-financial-results-and-corporate-progress\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/www.centogene.com\/centogene-reports-first-quarter-2020-financial-results-and-corporate-progress\/","url":"https:\/\/www.centogene.com\/centogene-reports-first-quarter-2020-financial-results-and-corporate-progress\/","name":"CENTOGENE publikuje wyniki finansowe i post\u0119py firmy za pierwszy kwarta\u0142 2020 r. | CENTOGENE","isPartOf":{"@id":"https:\/\/www.centogene.com\/#website"},"datePublished":"2020-06-15T00:00:00+00:00","breadcrumb":{"@id":"https:\/\/www.centogene.com\/centogene-reports-first-quarter-2020-financial-results-and-corporate-progress\/#breadcrumb"},"inLanguage":"pl-PL","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.centogene.com\/centogene-reports-first-quarter-2020-financial-results-and-corporate-progress\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.centogene.com\/centogene-reports-first-quarter-2020-financial-results-and-corporate-progress\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.centogene.com\/"},{"@type":"ListItem","position":2,"name":"CENTOGENE Reports First-Quarter 2020 Financial Results and Corporate Progress"}]},{"@type":"WebSite","@id":"https:\/\/www.centogene.com\/#website","url":"https:\/\/www.centogene.com\/","name":"CENTOGENE","description":"Wyznaczanie kierunku medycyny precyzyjnej","publisher":{"@id":"https:\/\/www.centogene.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.centogene.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"pl-PL"},{"@type":"Organization","@id":"https:\/\/www.centogene.com\/#organization","name":"CENTOGENE","url":"https:\/\/www.centogene.com\/","logo":{"@type":"ImageObject","inLanguage":"pl-PL","@id":"https:\/\/www.centogene.com\/#\/schema\/logo\/image\/","url":"https:\/\/www.centogene.com\/wp-content\/uploads\/2026\/04\/CENTOGENE-Flower.png","contentUrl":"https:\/\/www.centogene.com\/wp-content\/uploads\/2026\/04\/CENTOGENE-Flower.png","width":246,"height":246,"caption":"CENTOGENE"},"image":{"@id":"https:\/\/www.centogene.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.linkedin.com\/company\/centogene","https:\/\/www.youtube.com\/channel\/UClZxtN_laC1_ZtCdxkasdPQ","https:\/\/www.instagram.com\/_centogene_\/"]},{"@type":"Person","@id":"https:\/\/www.centogene.com\/#\/schema\/person\/d9b8738539a9ddb5de5a02a909d40b8b","name":"admincg","url":"https:\/\/www.centogene.com\/pl\/author\/admincg\/"}]}},"_links":{"self":[{"href":"https:\/\/www.centogene.com\/pl\/wp-json\/wp\/v2\/posts\/2345","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.centogene.com\/pl\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.centogene.com\/pl\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.centogene.com\/pl\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.centogene.com\/pl\/wp-json\/wp\/v2\/comments?post=2345"}],"version-history":[{"count":0,"href":"https:\/\/www.centogene.com\/pl\/wp-json\/wp\/v2\/posts\/2345\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.centogene.com\/pl\/wp-json\/wp\/v2\/media?parent=2345"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.centogene.com\/pl\/wp-json\/wp\/v2\/categories?post=2345"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.centogene.com\/pl\/wp-json\/wp\/v2\/tags?post=2345"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}